Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers
MAFLD, particularly in the presence of advanced liver fibrosis, is strongly and independently associated with hypertension in young adults. Systemic inflammation acts as a key mediator in this relationship, highlighting its potential as a therapeutic target for precision antihypertensive strategies in this population.
Authors
- Chengzhi Lu (ORCID: https://orcid.org/0000-0002-7839-4383)
- Jia Zheng (ORCID: https://orcid.org/0000-0003-0891-5339)
Institutions
- Tianjin First Center Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Clinical and Experimental Hypertension
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1080/10641963.2025.2597852
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00